These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4762633)
21. Some properties of phenylethanolamine-N-methyltransferase of rat brain. Díaz Borges JM; Urbina M; Drujan BD Neurochem Res; 1978 Feb; 3(1):15-26. PubMed ID: 683413 [TBL] [Abstract][Full Text] [Related]
22. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. II. Control of the thermal stability of the enzyme by an endogenous stabilizing factor. Ciaranello RD; Wong DL; Berenbeim DM Mol Pharmacol; 1978 May; 14(3):490-501. PubMed ID: 207972 [No Abstract] [Full Text] [Related]
23. Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase. Fuller RW; Hemrick-Luecke SK; Perry KW Biochem Pharmacol; 1983 Jan; 32(2):215-20. PubMed ID: 6870951 [No Abstract] [Full Text] [Related]
24. Proceedings: The phenylethanolamine-N-methyl transferase (PNMT) activity in various organs of the chicken. Lindmar R; Wolf U Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R2. PubMed ID: 1143401 [No Abstract] [Full Text] [Related]
25. Molecular recognition of sub-micromolar inhibitors by the epinephrine-synthesizing enzyme phenylethanolamine N-methyltransferase. McMillan FM; Archbold J; McLeish MJ; Caine JM; Criscione KR; Grunewald GL; Martin JL J Med Chem; 2004 Jan; 47(1):37-44. PubMed ID: 14695818 [TBL] [Abstract][Full Text] [Related]
26. A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Henry DP; Starman BJ; Johnson DG; Williams RH Life Sci; 1975 Feb; 16(3):375-84. PubMed ID: 1128155 [No Abstract] [Full Text] [Related]
27. Synthesis and characterization of an immobilized phenylethanolamine N-methyltransferase liquid chromatographic stationary phase. Markoglou N; Wainer IW Anal Biochem; 2001 Jan; 288(1):83-8. PubMed ID: 11141309 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of norepinephrine N-methyltransferase by 1-aminoindans, conformationally rigid analogs of benzylamines. Fuller RW; Roush BW; Hemrick SK; Snoddy HD; Molloy BB Life Sci; 1978 Apr; 22(16):1421-7. PubMed ID: 672406 [No Abstract] [Full Text] [Related]
29. 5'-thioadenosine derivatives as potent and selective inhibitors of histamine N-methyltransferase. Crooks PA; Hassan SF; Benghiat E; Hemrick-Luecke SK; Fuller RW Drug Metabol Drug Interact; 1989; 7(2-3):111-41. PubMed ID: 2630176 [TBL] [Abstract][Full Text] [Related]
30. Kinetics of product inhibition of rabbit lung N-methyltransferase. Krause RR; Domino EF Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):359-74. PubMed ID: 4531088 [No Abstract] [Full Text] [Related]
31. Specific photoactivated covalent binding of S-adenosylmethionine to phenylethanolamine-N-methyl transferase. Yu PH Biochim Biophys Acta; 1983 Feb; 742(3):517-24. PubMed ID: 6838886 [TBL] [Abstract][Full Text] [Related]
32. Identification of the essential cysteinyl residue located in the active site of human phenylethanolamine N-methyltransferase. Kaneda N; Hikita K; Naruse Y; Fukuo T; Matsubara K; Nagatsu T Biochem Biophys Res Commun; 1998 Aug; 249(2):405-9. PubMed ID: 9712709 [TBL] [Abstract][Full Text] [Related]
33. Evidence that dopamine is not a substrate for adrenal phenylethanolamine N-methyltransferase. Pendleton RG; Gessner G Mol Pharmacol; 1975 Mar; 11(2):232-5. PubMed ID: 1124081 [No Abstract] [Full Text] [Related]
34. Photoaffinity labelling of methyltransferase enzymes with S-adenosylmethionine: effects of methyl acceptor substrates. Hurst JH; Billingsley ML; Lovenberg W Biochem Biophys Res Commun; 1984 Jul; 122(2):499-508. PubMed ID: 6380498 [TBL] [Abstract][Full Text] [Related]
35. Axonal transport of phenylethanolamine-N-methyltransferase in toad sciatic nerve. Wooten GF; Saavedra JM J Neurochem; 1974 Jun; 22(6):1059-64. PubMed ID: 4211826 [No Abstract] [Full Text] [Related]
36. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats. Hahn RA; Fuller RW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549 [No Abstract] [Full Text] [Related]
37. Adrenal phenylethanolamine-N-methyltransferase activity in the young rat: influence of thyroid hormones and insulin-induced hypoglycemia. Gripois D; Valens M Biol Neonate; 1986; 49(4):219-23. PubMed ID: 3518820 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of dimethyltryptamine biosynthesis by N,N'-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II). Mandel LR; Rokach J; Rooney CS; Cragoe EJ Mol Pharmacol; 1978 Sep; 14(5):930-9. PubMed ID: 280749 [No Abstract] [Full Text] [Related]
39. Inhibition of indolethylamine-N-methyltransferase by S-adenosylhomocysteine. Lin RL; Narasimhachari N; Himwich HE Biochem Biophys Res Commun; 1973 Sep; 54(2):751-9. PubMed ID: 4756800 [No Abstract] [Full Text] [Related]
40. Isolation of multiple forms of rabbit-adrenal norepinephrine N-methyltransferase. Lee HS; Schulz AR; Fuller RW Arch Biochem Biophys; 1974 Aug; 163(2):735-41. PubMed ID: 4414012 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]